Amolyt Pharma

Business Data, Corporate Office and Headquarter Address

About

Amolyt Pharma is Drug Discovery in France that focus on therapeutic peptide business. Founded in 2014. They cover business area such as developer, biopharmaceutical drug, endocrine, metabolic, disorder, severe insulin resistance, Hypoparathyroidism, sustained level, calcium, healthcare professional, patient.

Business Type

Drug Discovery

Country

France

Founded

2014
( 10 years old in 2024 )

Company Focus

Therapeutic Peptide

Website

-

Corporate Office and Headquarter Office address:

15, Chemin Du Saquin
Espace Européen, Building G, Ecully
69130 Lyon
France

Phone number:

Private

Office Opening Hours*:

Monday 9.30 - 17.00
Tuesday 9.30 - 17.00
Wednesday 9.30 - 17.00
Thursday 9.30 - 17.00
Friday 9.30 - 17.00
Saturday Closed
Sunday Closed

Business Coverage

developerbiopharmaceutical drugendocrinemetabolicdisordersevere insulin resistanceHypoparathyroidismsustained levelcalciumhealthcare professionalpatient

* We use standard office opening hours in near Amolyt Pharma's location as default value for unknown and outdated data. For more valid info, please verify the info from more trusted sources like GoogleMyBusiness, Yelp, FourSquare or similar services.

Amolyt Pharma Frequently Asked Questions

What or who is Amolyt Pharma?

Amolyt Pharma is Drug Discovery business from France that founded in 2014 (10 years old in 2024), Amolyt Pharma business is focusing on Therapeutic Peptide.

Where is Amolyt Pharma headquarter and corporate office address?

Amolyt Pharma headquarter office and corporate office address is located in 15, Chemin Du Saquin Espace Européen, Building G, Ecully 69130 Lyon France.

Where is Amolyt Pharma country origins?

Amolyt Pharma was founded in France.

What is Therapeutic Peptide business focus on?

In 2024, Amolyt Pharma is currently focus on therapeutic peptide sector.

Therapeutic Peptide Business Interest from Google Trend

Above is snippet of Google Trends for "therapeutic peptide" term, if you have problem loading the snippet, please visit here: Google Trend.

Disclaimer: This website is not affiliated with Amolyt Pharma, any government agency, does not create this data, vouch for its accuracy, or guarantee that it is the most recent data available. The data displayed is available through open government websites and public online directory. This website expressly disclaims the accuracy, adequacy, or completeness of any data and shall not be liable for any errors, omissions or other defects in, delays or interruptions in such data, or for any actions taken in reliance thereon.